NetScientific Shares Jump as Portfolio Company PDS Collaborates With Merck & Co

Date : 10/03/2019 @ 1:28PM
Source : Dow Jones News
Stock : Merck and Co Inc (MRK)
Quote : 84.65  0.52 (0.62%) @ 12:59AM
After Hours
Last Trade
Last $ 84.68 ▲ 0.03 (0.04%)

NetScientific Shares Jump as Portfolio Company PDS Collaborates With Merck & Co

Netscientific (LSE:NSCI)
Historical Stock Chart

2 Months : From Sep 2019 to Nov 2019

Click Here for more Netscientific Charts.

By Adria Calatayud


Shares in NetScientific PLC (NSCI.LN) rose Thursday after it said portfolio company PDS Biotechnology Corp. (PDSB) will collaborate with U.S. drug maker Merck & Co. Inc. (MRK) in a phase II clinical trial.

NetScientific, a London-based healthcare technology company, said the trial will study PDS's lead product, PDS0101, in combination with Merck's cancer drug Keytruda as a first line treatment in patients with recurrent or metastatic head and neck cancer and high-risk human papillomavirus-16 infection.

Shares in NetScientific at 1256 GMT were up 40% at 8.75 pence.


Write to Adria Calatayud at


(END) Dow Jones Newswires

October 03, 2019 09:13 ET (13:13 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest MRK Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.